Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05ICS
|
|||
| Former ID |
DIB004891
|
|||
| Drug Name |
ProSavin
|
|||
| Synonyms |
Dopamine synthesis pathway gene therapy (Parkinson's disease), Oxford BioMedica
Click to Show/Hide
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 1/2 | [1] | |
| Company |
Oxford BioMedica plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01856439) Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Oxford BioMedica. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.